论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
白藜芦醇与 2 型糖尿病患者的肾功能生物标志物:随机对照试验的最新系统评价和荟萃分析
Authors Gu W, Mu N, Yan Y, Shi L, Yang F
Received 22 October 2025
Accepted for publication 12 January 2026
Published 28 January 2026 Volume 2026:19 402309
DOI https://doi.org/10.2147/DMSO.S402309
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Rebecca Baqiyyah Conway
Wei Gu,1,* Na Mu,2,* Yan Yan,3 Liwei Shi,1 Fan Yang1
1Department of Endocrinology, Harrison International Peace Hospital, Hengshui, Hebei, People’s Republic of China; 2Department of Clinical Laboratory, Harrison International Peace Hospital, Hengshui, Hebei, People’s Republic of China; 3Endocrinology Department, Hengshui Fourth People’s Hospital, Hengshui, Hebei, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Wei Gu, Email lucky1629@163.com
摘要:
目的:本研究旨在系统评估白藜芦醇(RSV)补充对2型糖尿病(T2DM)患者肾损伤相关指标的影响。
方法:这项系统评价和荟萃分析纳入了12项随机对照试验(RCTs),共636名2型糖尿病患者。为确保证据质量最高,分析仅针对RCTs进行。
结果:血尿素氮(WMD:-0.01;95% CI:-0.66 - 0.63;P=0.97)或血清肌酐(SMD:0.05;95% CI:-0.13 - 0.23;P=0.56)均无显著变化。亚组分析显示,无论RSV剂量或干预持续时间如何,均无显著差异。相比之下,RSV补充导致血清尿酸轻度降低(-0.42 mg/dL)(WMD:-0.42;95% CI:-0.65 - -0.18;P=0.0005),且纳入研究间异质性较低(I²=0%)。
结论:这项系统评价和荟萃分析提供了最新证据,表明RSV可显著降低2型糖尿病患者的血清尿酸水平,尽管对血尿素氮和肌酐无显著影响。这种特定的降尿酸作用提示RSV在管理高尿酸血症方面可能具有潜在作用,而高尿酸血症是2型糖尿病的常见合并症,会增加肾脏和心血管风险。